Home / Import refusals / SCS-3328257-6/31/1

FDA Import Refusal SCS-3328257-6/31/1 — Mayne Pharma International PTY LTD

Mayne Pharma International PTY LTD — FEI 3004090027

The FDA refused shipment SCS-3328257-6/31/1 from Mayne Pharma International PTY LTD (Australia) on March 14, 2019. The refused product falls under Drugs and Biologics — CLOZAPINE (SEDATIVE). Cited charges: 118,75 This firm has 2 other import refusals on record.

Refusal Details

Date
March 14, 2019
Country
Australia
Product Category
Drugs and Biologics
Product Code
65VCY13 CLOZAPINE (SEDATIVE)
Charges
118,75

Recent inspections

  • 1257835 (VAI Fri Mar 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110711 (VAI Fri Oct 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035729 (NAI Fri Sep 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945811 (VAI Fri Sep 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 846520 (VAI Fri Aug 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-0689980-3/11/1 (Mon Jul 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • BPQ-7014562-3/1/1 (Thu Mar 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources